FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1774239930> ?p ?o ?g. }

• W1774239930 abstract "Abstract Background Prostate cancer is the most commonly diagnosed malignancy in men and is thought to arise as a result of endogenous oxidative stress in the face of compromised carcinogen defenses. We tested whether carcinogen defense (phase 2) enzymes could be induced in the prostate tissues of rats after oral feeding of candidate phase 2 enzyme inducing compounds. Methods Male F344 rats were gavage fed sulforaphane, β-naphthoflavone, curcumin, dimethyl fumarate or vehicle control over five days, and on the sixth day, prostate, liver, kidney and bladder tissues were harvested. Cytosolic enzyme activities of nicotinamide quinone oxidoreductase (NQO1), total glutathione transferase (using DCNB) and mu-class glutathione transferase (using CDNB) were determined in the treated and control animals and compared. Results In prostatic tissues, sulforaphane produced modest but significant increases in the enzymatic activities of NQO1, total GST and GST-mu compared to control animals. β-naphthoflavone significantly increased NQO1 and GST-mu activities and curcumin increased total GST and GST-mu enzymatic activities. Dimethyl fumarate did not significantly increase prostatic phase 2 enzyme activity. Compared to control animals, sulforaphane also significantly induced NQO1 or total GST enzyme activity in the liver, kidney and, most significantly, in the bladder tissues. All compounds were well tolerated over the course of the gavage feedings. Conclusion Orally administered compounds will induce modestly phase 2 enzyme activity in the prostate although the significance of this degree of induction is unknown. The 4 different compounds also altered phase 2 enzyme activity to different degrees in different tissue types. Orally administered sulforaphane potently induces phase 2 enzymes in bladder tissues and should be investigated as a bladder cancer preventive agent." @default.
• W1774239930 created "2016-06-24" @default.
• W1774239930 creator A5022192007 @default.
• W1774239930 creator A5022762690 @default.
• W1774239930 date "2006-03-15" @default.
• W1774239930 modified "2023-09-27" @default.
• W1774239930 title "Modest induction of phase 2 enzyme activity in the F-344 rat prostate" @default.
• W1774239930 cites W1580316843 @default.
• W1774239930 cites W1581414347 @default.
• W1774239930 cites W1968391853 @default.
• W1774239930 cites W1969962178 @default.
• W1774239930 cites W1975827192 @default.
• W1774239930 cites W1994116295 @default.
• W1774239930 cites W1995604720 @default.
• W1774239930 cites W1997506075 @default.
• W1774239930 cites W1998128080 @default.
• W1774239930 cites W2004797953 @default.
• W1774239930 cites W2004850862 @default.
• W1774239930 cites W2010397777 @default.
• W1774239930 cites W2013092934 @default.
• W1774239930 cites W2025362880 @default.
• W1774239930 cites W2042038575 @default.
• W1774239930 cites W2046677907 @default.
• W1774239930 cites W2053821985 @default.
• W1774239930 cites W2062030901 @default.
• W1774239930 cites W2064035407 @default.
• W1774239930 cites W2065366305 @default.
• W1774239930 cites W2068075238 @default.
• W1774239930 cites W2071407395 @default.
• W1774239930 cites W2086478724 @default.
• W1774239930 cites W2087315272 @default.
• W1774239930 cites W2095364552 @default.
• W1774239930 cites W2101083359 @default.
• W1774239930 cites W2109257673 @default.
• W1774239930 cites W2109799715 @default.
• W1774239930 cites W2129528814 @default.
• W1774239930 cites W2148114677 @default.
• W1774239930 cites W2163895012 @default.
• W1774239930 cites W2171691536 @default.
• W1774239930 cites W2312461597 @default.
• W1774239930 cites W4232547688 @default.
• W1774239930 cites W4254280874 @default.
• W1774239930 cites W4293247451 @default.
• W1774239930 cites W4295115868 @default.
• W1774239930 doi "https://doi.org/10.1186/1471-2407-6-62" @default.
• W1774239930 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1421427" @default.
• W1774239930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16539699" @default.
• W1774239930 hasPublicationYear "2006" @default.
• W1774239930 type Work @default.
• W1774239930 sameAs 1774239930 @default.
• W1774239930 citedByCount "37" @default.
• W1774239930 countsByYear W17742399302012 @default.
• W1774239930 countsByYear W17742399302013 @default.
• W1774239930 countsByYear W17742399302014 @default.
• W1774239930 countsByYear W17742399302015 @default.
• W1774239930 countsByYear W17742399302016 @default.
• W1774239930 countsByYear W17742399302017 @default.
• W1774239930 countsByYear W17742399302020 @default.
• W1774239930 countsByYear W17742399302021 @default.
• W1774239930 crossrefType "journal-article" @default.
• W1774239930 hasAuthorship W1774239930A5022192007 @default.
• W1774239930 hasAuthorship W1774239930A5022762690 @default.
• W1774239930 hasBestOaLocation W17742399301 @default.
• W1774239930 hasConcept C114246631 @default.
• W1774239930 hasConcept C121608353 @default.
• W1774239930 hasConcept C126322002 @default.
• W1774239930 hasConcept C132154277 @default.
• W1774239930 hasConcept C134018914 @default.
• W1774239930 hasConcept C181199279 @default.
• W1774239930 hasConcept C185592680 @default.
• W1774239930 hasConcept C2776151105 @default.
• W1774239930 hasConcept C2776235491 @default.
• W1774239930 hasConcept C2776907368 @default.
• W1774239930 hasConcept C2778250585 @default.
• W1774239930 hasConcept C2780091579 @default.
• W1774239930 hasConcept C2780841255 @default.
• W1774239930 hasConcept C28212737 @default.
• W1774239930 hasConcept C538909803 @default.
• W1774239930 hasConcept C55493867 @default.
• W1774239930 hasConcept C71924100 @default.
• W1774239930 hasConcept C98274493 @default.
• W1774239930 hasConceptScore W1774239930C114246631 @default.
• W1774239930 hasConceptScore W1774239930C121608353 @default.
• W1774239930 hasConceptScore W1774239930C126322002 @default.
• W1774239930 hasConceptScore W1774239930C132154277 @default.
• W1774239930 hasConceptScore W1774239930C134018914 @default.
• W1774239930 hasConceptScore W1774239930C181199279 @default.
• W1774239930 hasConceptScore W1774239930C185592680 @default.
• W1774239930 hasConceptScore W1774239930C2776151105 @default.
• W1774239930 hasConceptScore W1774239930C2776235491 @default.
• W1774239930 hasConceptScore W1774239930C2776907368 @default.
• W1774239930 hasConceptScore W1774239930C2778250585 @default.
• W1774239930 hasConceptScore W1774239930C2780091579 @default.
• W1774239930 hasConceptScore W1774239930C2780841255 @default.
• W1774239930 hasConceptScore W1774239930C28212737 @default.
• W1774239930 hasConceptScore W1774239930C538909803 @default.
• W1774239930 hasConceptScore W1774239930C55493867 @default.
• W1774239930 hasConceptScore W1774239930C71924100 @default.
• W1774239930 hasConceptScore W1774239930C98274493 @default.
• W1774239930 hasIssue "1" @default.

• next